Clinical Trials Sponsored by Cerebos

Total 48 results

Cerebos Pacific Limited

Unknown

CMI-168 on Cognitive Function in Healthy Middle-aged Men and Women

Cognitive Change

Taiwan
Sprim Advanced Life Sciences
Cerebos

Completed

Effects of Essence of Chicken on Physical Fatigue, Working Memory and Attention

Fatigue | Healthy Subjects
Carebot s.r.o.

Completed

Retrospective Study of Carebot AI CXR Performance in Preclinical Practice

Pneumonia | Lung Diseases | Pneumothorax | Lung Cancer | Cardiomegaly | Artificial Intelligence | Pulmonary Edema | Pleural Effusion | Atelectasis | Consolidation | Hilar Calcification | Fracture Rib

Czechia
Cerebra Medical

Completed

Prodigy, a Level 2 Sleep Study Device, Validation Study

Sleep Apnea

United States, Canada
Carebot s.r.o.

Completed

Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice

Pneumothorax | Subcutaneous Emphysema | Cardiomegaly | Pleural Effusion | Atelectasis | Pulmonary Nodule, Solitary | Consolidation

Czechia
Tereos
BioFortis

Active, not recruiting

Study to Assess the Effects of Non Digestible Carbohydrates on Long-Term Glucose Homeostasis in Untreated Prediabetic Subjects (FOS_GLUCOSE)

PreDiabetes | Prediabetic State | Pre Diabetes | Dysglycemia

France
Cerenis Therapeutics, SA

Completed

Exploratory Study of Plaque Regression (EXPRESS)

Heterozygous Familial Hypercholesterolemia

Canada
Cerenis Therapeutics, SA

Terminated

CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases (TANGO)

Familial Hypoalphalipoproteinemia

France, United States, Belgium, Canada, Israel, Italy, Netherlands
Cerenis Therapeutics, SA

Completed

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects (MODE)

Homozygous Familial Hypercholesterolemia

United States, Canada, Italy, Netherlands, United Kingdom
Cerenis Therapeutics, SA

Completed

Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial (CHI SQUARE)

Acute Coronary Syndrome

Canada, United States, France, Netherlands
Cereno Scientific AB

Completed

Study Investigation Pharmacokinetics and Pharmacodynamics of CS1

Thrombosis

Sweden
Tereos
CEN Biotech

Completed

Evaluation of Gastrointestinal Comfort Following Regular Consumption of Short-chain Fructo-oligosaccharides (10-20 g Per Day) by Children Aged 6-12 Years (FOSTI)

Gastrointestinal Tract

France
Shan May Yong
Chang Gung Memorial Hospital

Completed

Effects of Chicken Extract and Collagen on Mobility

Knee Osteoarthritis | Muscle Loss

Taiwan
Clinical Nutrition Research Centre, Singapore
Cerebos Asia Pacific Pte Ltd

Completed

Glycemic Response of Co-ingesting Carbohydrate and Amino Acids

Metabolic Diseases
Cerebra Medical
University of Manitoba

Suspended

Patient Outcomes in Unattended and In- Lab Polysomnography

Sleep Apnea | Hypersomnia

Canada
Cerebra Medical
Ekosi Health Centre

Recruiting

Assessment of Sleep Quality in Cannabinoid Therapy

Poor Sleep Quality

Canada
Egyptian Cerebro-Cardio-Vascular Association

Unknown

Risk Profiling for Patients With Isolated or Combined Coronary and Cerebral Ischemia, and Current Management Status

Risk Factor, Cardiovascular | Ischemia, Myocardial | Ischemia, Cerebral
Instituto do Cerebro de Brasilia

Completed

Medical Education in a Private Hospital

Health Care Quality, Access, and Evaluation
Eucatech AG
CERES GmbH

Unknown

Prospective multicEntric NonranDomized Registry (ExPEND)

Coronary Artery Disease
Cereb AB
Karolinska Institutet

Unknown

Short Structured Psychological Intervention for Adults With ADHD - a Randomized Controlled Trial

Attention Deficit Disorder With Hyperactivity

Sweden
Instituto do Cerebro de Brasilia
Hospital Sao Lucas da PUCRS; Instituto do Cerebro da PUCRS

Completed

Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy

Epilepsy

Brazil
Nano4Imaging GmbH
CERES GmbH

Completed

Post-market Clinical Follow-up Study With Magnetic Resonance Imaging Conditional Guide Wire (MRWIREPMCF)

Congenital Heart Defect

Germany, United Kingdom
University of Reading
Jordans Cereals (Biggleswade, UK)

Completed

Health Benefits of Whole Grain Oats in Population at Risk of Cardio-metabolic Disease

Cardiovascular Disease | Hypercholesterolemia

United Kingdom
Cereno Scientific AB
Worldwide Clinical Trials

Recruiting

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Sweden
Herrmann Apparatebau GmbH
CERES GmbH

Unknown

Evaluation of Performance and Safety of Colonic Irrigation With the Colon Hydromat as a Non-oral Bowel Preparation for Colonoscopy

Colonic Irrigation

Germany
Cereno Scientific AB
Abbott; Worldwide Clinical Trials

Available

Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Sweden
Ceres Heilmittel AG
University of Zurich

Completed

Low Dose St John's Wort for Depression

Major Depression

Switzerland
ANM Adaptive Neuromodulation GmbH
CERES GmbH

Completed

Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life") (RRL)

Tinnitus

Germany
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions

22q11.2 Deletion Syndrome

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Attention Deficit Disorder With Hyperactivity

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury

Acute Lung Injury | ARDS | COVID-19 Pneumonia

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

Attention Deficit Hyperactivity Disorder

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Cerenis Therapeutics, SA
South Australian Health and Medical Research Institute

Completed

CER-001 Atherosclerosis Regression ACS Trial (CARAT)

Acute Coronary Syndromes

United States, Australia, Netherlands, Hungary
Fresenius Medical Care Deutschland GmbH
CERES GmbH

Recruiting

Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy (multiECCO2R)

Covid19 | Acute Kidney Injury | Acute Lung Injury | Hypercapnia

Germany
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Terminated

TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)

Anemia of End Stage Renal Disease

Israel
Hemoteq AG
CERES GmbH; coreLab Black Forest GmbH

Completed

Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Claudication

Germany, Austria, France
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Completed

TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)

End Stage Renal Disease | Chronic Kidney Disease

Israel
Aevi Genomic Medicine, LLC, a Cerecor company
Medgenics Medical Israel Ltd.

Terminated

TARGTEPO Treatment for Anemia in PD US Trial

Anemia of End Stage Renal Disease

United States
Joselyn Cerezo, MD
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) (CLEVER)

Cardiovascular Diseases | Peripheral Vascular Diseases | Atherosclerosis

United States, Canada
Aevi Genomic Medicine, LLC, a Cerecor company
Children's Hospital of Philadelphia; Thomas Jefferson University; Pearson/Clinical...

Completed

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder (NFC1-GREAT)

Attention-deficit Hyperactivity Disorder (ADHD)

United States
Universidad Miguel Hernandez de Elche
Universidad Catolica Santiago de Guayaquil; Hospital General del Norte de Guayaquil...

Completed

SER+ Against COVID-19 - Interventions to Strengthen the Resilience of HCWs in Ecuador

Occupational Stress | Stress, Physiological

Ecuador
Universidad de Granada
Hospital Clinico Universitario San Cecilio; Centro de Investigación Biomédica; Instituto Mixto Universitario Deporte y Salud and other collaborators

Completed

Effects of an Exercise Program on Cognition and Brain in Overweight/Obese Preadolescent Children (ActiveBrains)

Obesity | Overweight | Mental Health Wellness 1 | Cognitive Function 1, Social
Universidad de Granada
University of Pittsburgh; University Hospital Virgen de las Nieves; Instituto... and other collaborators

Completed

Active Gains in Brain Using Exercise During Aging (AGUEDA)

Healthy | Cognitive Function 1, Social

Spain
Universidad de Granada
Hospital Clinico Universitario San Cecilio; University Hospital Virgen de las... and other collaborators

Enrolling by invitation

Exercise and Brain in Coronary Heart Disease (Heart-Brain)

Coronary Heart Disease

Spain

Clinical Trials Sponsored by Cerebos

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations